Login / Signup
Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.
Ashish Srinivasan
Peter De Cruz
Daniel R Van Langenberg
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
rheumatoid arthritis
ulcerative colitis
patients with inflammatory bowel disease